Targeting hepatic stellate cells to combat liver fibrosis: where do we stand?

被引：5
|
作者：
Breitkopf-Heinlein, Katja [1 ]
Martinez-Chantar, Maria Luz [2 ]
机构：
[1] Heidelberg Univ, Univ Med Ctr Mannheim, Med Fac Mannheim, Dept Surg, D-68167 Mannheim, Baden Wurttembe, Germany
[2] Ctr Cooperat Res Biosci, Liver Dis Lab, Derio, Spain
来源：
GUT | 2024年 / 73卷 / 09期
关键词：
CELL BIOLOGY; CHRONIC LIVER DISEASE;
D O I：
10.1136/gutjnl-2023-331785
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1411 / 1413
页数：3
相关论文
共 50 条
  • [41] Tyrosine kinase inhibitor neratinib attenuates liver fibrosis by targeting activated hepatic stellate cells
    Park, Yong Joo
    An, Hyoung-Tae
    Park, Jong-Sung
    Park, Ogyi
    Duh, Alexander J.
    Kim, Kwangmeyung
    Chung, Kyu Hyuck
    Lee, Kang Choon
    Oh, Yumin
    Lee, Seulki
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [42] WHERE DO WE STAND
    不详
    MILITARY MEDICINE, 1961, 126 (01) : 66 - &
  • [43] Tyrosine kinase inhibitor neratinib attenuates liver fibrosis by targeting activated hepatic stellate cells
    Yong Joo Park
    Hyoung-Tae An
    Jong-Sung Park
    Ogyi Park
    Alexander J. Duh
    Kwangmeyung Kim
    Kyu Hyuck Chung
    Kang Choon Lee
    Yumin Oh
    Seulki Lee
    Scientific Reports, 10
  • [44] Oleoylethanolamide, an endogenous PPAR-α ligand, attenuates liver fibrosis targeting hepatic stellate cells
    Chen, Ling
    Li, Long
    Chen, Junde
    Li, Lei
    Zheng, Zihan
    Ren, Jie
    Qiu, Yan
    ONCOTARGET, 2015, 6 (40) : 42530 - 42540
  • [45] Targeting Hepatic Stellate Cells for the Treatment of Liver Fibrosis by Natural Products: Is It the Dawning of a New Era?
    Chan, Yau-Tuen
    Wang, Ning
    Tan, Hor Yue
    Li, Sha
    Feng, Yibin
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [46] Engineered liposomes targeting hepatic stellate cells overcome pathological barriers and reverse liver fibrosis
    Wang, Kaili
    Chen, Hao
    Zheng, Jiani
    Chen, Jiali
    Chen, Yixuan
    Yuan, Yue
    JOURNAL OF CONTROLLED RELEASE, 2024, 368 : 219 - 232
  • [47] Prevention of rat liver fibrosis by selective targeting of hepatic stellate cells using hesperidin carriers
    Morsy, Mohamed A.
    Nair, Anroop B.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2018, 552 (1-2) : 241 - 250
  • [48] Assessment of Liver Function With MRI: Where Do We Stand?
    Rio Bartulos, Carolina
    Senk, Karin
    Schumacher, Mona
    Plath, Jan
    Kaiser, Nico
    Bade, Ragnar
    Woetzel, Jan
    Wiggermann, Philipp
    FRONTIERS IN MEDICINE, 2022, 9
  • [49] Living liver donor mortality: Where do we stand?
    Bramstedt, KA
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (04): : 755 - 759
  • [50] Liver transplantation for hepatocellular carcinoma: Where do we stand?
    Santopaolo, Francesco
    Lenci, Ilaria
    Milana, Martina
    Manzia, Tommaso Maria
    Baiocchi, Leonardo
    WORLD JOURNAL OF GASTROENTEROLOGY, 2019, 25 (21) : 2591 - 2602
12345